Archean Chemical Industries reported a 26% year-on-year rise in consolidated revenue to Rs 301.6 crore for Q2FY27, driven by strong demand in its bromine and derivatives segments. While bromine revenue surged 76%, profitability saw a modest rise to Rs 31.3 crore. The company is currently pivoting toward high-growth sectors including semiconductor materials and zinc-bromide battery storage to diversify its revenue base beyond industrial salt.
Archean Chemical Reports Revenue Growth in Q2
Consolidated revenue stood at Rs 301.6 crore; Profit after tax reached Rs 31.3 crore.
Reader Takeaway: Strong growth in bromine-based specialty chemicals faces headwinds from logistical bottlenecks and rising capital-intensive diversification costs.
What just happened
Archean Chemical Industries announced its Q2FY27 results, reporting a 26% year-on-year increase in revenue. The growth was primarily led by the bromine segment, which saw a 76% jump, and bromine derivatives, which climbed 81%. However, the industrial salt segment experienced a moderation in volume to 0.8 million tons, which the company attributed to temporary logistical challenges that have since been resolved.
Why this matters
As a major player in the specialty chemicals space, Archean’s ability to scale high-value derivatives is critical for margin expansion. The shift in product mix—moving away from commodity-heavy industrial salt toward specialized bromine products—is intended to reduce cyclicality. Furthermore, the company is aggressively entering the semiconductor materials market with its SiC facility in Odisha and investing in zinc-bromide battery technology via its stake in Offgrid Energy Labs.
Strategic Developments
The company is making significant strides in its diversification roadmap. Its integrated silicon carbide (SiC) semiconductor facility in Odisha is under construction, backed by a fiscal support agreement with the India Semiconductor Mission. Additionally, the company has commissioned a 10 MWh pilot manufacturing line for zinc-bromide batteries in the UK, signaling a push into energy storage.
Risks to watch
Despite top-line growth, H1FY27 EBITDA fell to Rs 147.3 crore from Rs 155.3 crore in the previous year, highlighting margin pressures. Investors should track how the company balances its ongoing capital expenditure for new high-tech facilities against potential volatility in operational costs. Additionally, the dependency on local infrastructure for salt distribution remains a logistical variable.
Context metrics
Total income for H1FY27 rose to Rs 634.4 crore compared to Rs 540.2 crore in H1FY26. The EPS for Q2 stood at Rs 2.60 compared to Rs 2.36 in the same period last year.